These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22005235)

  • 21. Prevention of contrast agent-induced renal impairment in patients with chronic renal insufficiency and heart disease by high-dose intravenous N-acetylcysteine: a pilot-ministudy.
    Sochman J; Krizova B
    Kardiol Pol; 2006 Jun; 64(6):559-64; discussion 565-6. PubMed ID: 16810570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nephrotoxicity of contrast media and protective effects of acetylcysteine.
    Briguori C; Quintavalle C; De Micco F; Condorelli G
    Arch Toxicol; 2011 Mar; 85(3):165-73. PubMed ID: 21140133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does the prophylactic administration of N-acetylcysteine prevent acute kidney injury following cardiac surgery?
    Ashworth A; Webb ST
    Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):303-8. PubMed ID: 20570977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute Kidney Injury, AKI - Update 2018].
    Patschan D; Müller GA
    Dtsch Med Wochenschr; 2018 Aug; 143(15):1094-1096. PubMed ID: 30060280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible mechanisms for N-acetyl cysteine and taurine in ameliorating acute renal failure induced by cisplatin in rats.
    Shalby AB; Assaf N; Ahmed HH
    Toxicol Mech Methods; 2011 Sep; 21(7):538-46. PubMed ID: 21470069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dexpanthenol and N-acetylcysteine pretreatment in rats before renal ischemia/reperfusion injury.
    Sen H; Deniz S; Yedekci AE; Inangil G; Muftuoglu T; Haholu A; Ozkan S
    Ren Fail; 2014 Nov; 36(10):1570-4. PubMed ID: 25156619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carfilzomib-related acute kidney injury may be prevented by N-acetyl-L-cysteine.
    Wanchoo R; Khan S; Kolitz JE; Jhaveri KD
    J Oncol Pharm Pract; 2015 Aug; 21(4):313-6. PubMed ID: 24748581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
    Ristikankare A; Kuitunen T; Kuitunen A; Uotila L; Vento A; Suojaranta-Ylinen R; Salmenperä M; Pöyhiä R
    Br J Anaesth; 2006 Nov; 97(5):611-6. PubMed ID: 16914459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
    Brophy DF
    Ann Pharmacother; 2002 Sep; 36(9):1466-70. PubMed ID: 12196069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).
    ACT Investigators
    Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions.
    Buyukhatipoglu H; Sezen Y; Yildiz A; Bas M; Kirhan I; Ulas T; Turan MN; Taskin A; Aksoy N
    Pol Arch Med Wewn; 2010 Oct; 120(10):383-9. PubMed ID: 20980943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies.
    Hernandez SH; Howland M; Schiano TD; Hoffman RS
    Clin Toxicol (Phila); 2015; 53(10):941-9. PubMed ID: 26484583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commentary on "N-acetylcysteine (NAC) protects against acute kidney injury following prolonged pneumoperitoneum".
    Shebrain S
    J Surg Res; 2011 Dec; 171(2):e179-80. PubMed ID: 22001183
    [No Abstract]   [Full Text] [Related]  

  • 35. A drug to prevent renal failure?
    Kellum JA
    Lancet; 2003 Aug; 362(9384):589-90. PubMed ID: 12944054
    [No Abstract]   [Full Text] [Related]  

  • 36. N-acetylcysteine for the prevention of acute kidney injury after cardiac surgery.
    Sisillo E; Marenzi G
    J Clin Pharmacol; 2011 Nov; 51(11):1603-10. PubMed ID: 21233303
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the effects of N-acetyl cysteine and erdosteine in rats with renal injury caused by paracetamol intoxication.
    Kandiş H; Erkan ME; Yildirim U; Güneş H; Erbaş M; Yildirim HA; Gezer S; Kara IH
    Hum Exp Toxicol; 2011 Sep; 30(9):1350-8. PubMed ID: 21115557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Zhao SJ; Zhong ZS; Qi GX; Tian W
    Int J Cardiol; 2016 Oct; 221():251-9. PubMed ID: 27404685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-acetylcysteine (NAC) protects against acute kidney injury (AKI) following prolonged pneumoperitoneum in the rat.
    Seguro AC; Poli de Figueiredo LF; Shimizu MH
    J Surg Res; 2012 Jun; 175(2):312-5. PubMed ID: 21764077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.